Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AJU1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.701 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.697 |
CLV_PCSK_FUR_1 | 146 | 150 | PF00082 | 0.575 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.501 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.554 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.414 |
DOC_PP1_RVXF_1 | 22 | 28 | PF00149 | 0.535 |
DOC_PP2B_LxvP_1 | 73 | 76 | PF13499 | 0.459 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.615 |
DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.539 |
DOC_USP7_UBL2_3 | 170 | 174 | PF12436 | 0.638 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.568 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.601 |
LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.608 |
LIG_BRCT_BRCA1_1 | 85 | 89 | PF00533 | 0.606 |
LIG_CSL_BTD_1 | 25 | 28 | PF09270 | 0.452 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.556 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.561 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.531 |
LIG_LIR_Nem_3 | 52 | 58 | PF02991 | 0.436 |
LIG_SH3_3 | 162 | 168 | PF00018 | 0.607 |
LIG_SUMO_SIM_par_1 | 69 | 78 | PF11976 | 0.445 |
LIG_WW_3 | 89 | 93 | PF00397 | 0.428 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.652 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.587 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.602 |
MOD_CK2_1 | 161 | 167 | PF00069 | 0.754 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.642 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.576 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.605 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.552 |
MOD_N-GLC_1 | 160 | 165 | PF02516 | 0.471 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.545 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.668 |
MOD_Plk_1 | 160 | 166 | PF00069 | 0.589 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.572 |
MOD_SUMO_for_1 | 147 | 150 | PF00179 | 0.544 |
MOD_SUMO_rev_2 | 167 | 176 | PF00179 | 0.662 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.391 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJ04 | Leptomonas seymouri | 67% | 98% |
A0A0S4INX7 | Bodo saltans | 41% | 90% |
A0A1X0P8U1 | Trypanosomatidae | 38% | 91% |
A0A3S5H549 | Leishmania donovani | 94% | 100% |
A0A422NMF6 | Trypanosoma rangeli | 40% | 95% |
A4H3M0 | Leishmania braziliensis | 87% | 100% |
D0A262 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 79% |
E9ACK3 | Leishmania major | 93% | 100% |
E9AG47 | Leishmania infantum | 94% | 100% |